Candenas M L, Naline E, Sarria B, Advenier C
Instituto Universitario de Bio-Organica, La Laguna, Tenerife, Spain.
Eur J Pharmacol. 1992 Jan 21;210(3):291-7. doi: 10.1016/0014-2999(92)90418-4.
The three endothelins ET-1, ET-2 and ET-3 induced a potent contractile response in the human isolated bronchus with an intact epithelium, which proceeded on two different stages. The first stage was observed at low concentrations (high potency) (10(-12) to 10(-9) M) but corresponded to a low intrinsic activity (Emax maximal effect induced by ACh 10(-3) M), the second stage appeared at higher concentrations and corresponded to higher intrinsic activity. The rank order of potency for the two stages of contractile activity was ET-1 greater than ET-2 = ET-3. Removal of the epithelium significantly enhanced the two stages of the contractile responses to the three endothelins and abolished the differences in potency efficacy that were observed between ET-1, ET-2 and ET-3 when the epithelium was present. Phosphoramidon (10(-5) M), an enkephalinase inhibitor, was as potent as epithelium removal in enhancing the contractile responses to these agonists at low concentrations (first stage of contraction, 10(-16) to 10(-9) M). However, with high concentrations of endothelins (greater than 10(-9) M, second stage of contraction), phosphoramidon was less potent than epithelium removal in enhancing the contractile responses. In epithelium-denuded strips, preincubation with phosphoramidon did not further increase the maximal contractions induced by/or the potencies of ET-1, ET-2 or ET-3. After epithelium removal, responses to low doses of endothelins were attenuated by nicardipine (10(-6) M) whereas responses to high doses of the endothelins were not affected, as was also observed when the epithelium was present. (ABSTRACT TRUNCATED AT 250 WORDS)
三种内皮素ET-1、ET-2和ET-3在具有完整上皮的人离体支气管中诱导出强烈的收缩反应,该反应分两个不同阶段进行。第一阶段出现在低浓度(高效价)(10⁻¹²至10⁻⁹ M)时,但对应较低的内在活性(由10⁻³ M乙酰胆碱诱导的最大效应Emax),第二阶段出现在较高浓度时,对应较高的内在活性。收缩活性两个阶段的效价顺序为ET-1大于ET-2 = ET-3。去除上皮显著增强了对三种内皮素收缩反应的两个阶段,并消除了存在上皮时ET-1、ET-2和ET-3之间观察到的效价效力差异。磷酰胺(10⁻⁵ M),一种脑啡肽酶抑制剂,在低浓度(收缩第一阶段,10⁻¹⁶至10⁻⁹ M)增强对这些激动剂的收缩反应方面与去除上皮一样有效。然而,在高浓度内皮素(大于10⁻⁹ M,收缩第二阶段)时,磷酰胺在增强收缩反应方面不如去除上皮有效。在去上皮的条带中,用磷酰胺预孵育不会进一步增加ET-1、ET-2或ET-3诱导的最大收缩或效价。去除上皮后,低剂量内皮素的反应被尼卡地平(10⁻⁶ M)减弱,而高剂量内皮素的反应不受影响,这在存在上皮时也观察到。(摘要截短于250字)